Literature DB >> 16697301

Catatonia in autistic spectrum disorders: a medical treatment algorithm.

Max Fink1, Michael A Taylor, Neera Ghaziuddin.   

Abstract

Autism is a developmental syndrome with an unknown biology and inadequate therapeutics. Assessing the elements of the syndrome for the presence of depression, psychosis, mania, or catatonia, offers opportunities for systematic intervention. Since almost all descriptions of autism highlight the presence of motor symptoms that characterize catatonia, an assessment for this eminently treatable syndrome is recommended for all patients considered to be autistic. A minimum examination includes a catatonia rating scale and for those patients with defined catatonia, a lorazepam test. For those whose catatonia responds to lorazepam, high dose lorazepam therapy is recommended. If this fails, electroconvulsive therapy is recommended. The assessment and treatment of catatonia offers positive medical therapy for the victims of autism and their families.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16697301     DOI: 10.1016/S0074-7742(05)72014-6

Source DB:  PubMed          Journal:  Int Rev Neurobiol        ISSN: 0074-7742            Impact factor:   3.230


  14 in total

Review 1.  Consensus paper: pathological role of the cerebellum in autism.

Authors:  S Hossein Fatemi; Kimberly A Aldinger; Paul Ashwood; Margaret L Bauman; Charles D Blaha; Gene J Blatt; Abha Chauhan; Ved Chauhan; Stephen R Dager; Price E Dickson; Annette M Estes; Dan Goldowitz; Detlef H Heck; Thomas L Kemper; Bryan H King; Loren A Martin; Kathleen J Millen; Guy Mittleman; Matthew W Mosconi; Antonio M Persico; John A Sweeney; Sara J Webb; John P Welsh
Journal:  Cerebellum       Date:  2012-09       Impact factor: 3.847

Review 2.  Catatonia in patients with autism: prevalence and management.

Authors:  Luigi Mazzone; Valentina Postorino; Giovanni Valeri; Stefano Vicari
Journal:  CNS Drugs       Date:  2014-03       Impact factor: 5.749

3.  [Autism in adults with intellectual disabilities].

Authors:  T Sappok; T Bergmann; H Kaiser; A Diefenbacher
Journal:  Nervenarzt       Date:  2010-11       Impact factor: 1.214

4.  Electroconvulsive therapy for psychotropic-refractory bipolar affective disorder and severe self-injury and aggression in an 11-year-old autistic boy.

Authors:  Lee E Wachtel; Richard Jaffe; Charles H Kellner
Journal:  Eur Child Adolesc Psychiatry       Date:  2011-01-21       Impact factor: 4.785

Review 5.  A computational model for cerebral cortical dysfunction in autism spectrum disorders.

Authors:  Shashaank Vattikuti; Carson C Chow
Journal:  Biol Psychiatry       Date:  2009-10-31       Impact factor: 13.382

Review 6.  Catatonia in autism: implications across the life span.

Authors:  Angelina Kakooza-Mwesige; Lee E Wachtel; Dirk M Dhossche
Journal:  Eur Child Adolesc Psychiatry       Date:  2008-04-21       Impact factor: 4.785

Review 7.  A systematic review of interventions used to treat catatonic symptoms in people with autistic spectrum disorders.

Authors:  Hannah DeJong; Penny Bunton; Dougal J Hare
Journal:  J Autism Dev Disord       Date:  2014-09

8.  ECT for self-injury in an autistic boy.

Authors:  Lee E Wachtel; Stephanie A Contrucci-Kuhn; Merrie Griffin; Ainsley Thompson; Dirk M Dhossche; Irving M Reti
Journal:  Eur Child Adolesc Psychiatry       Date:  2009-02-05       Impact factor: 4.785

9.  A randomised controlled trial of bumetanide in the treatment of autism in children.

Authors:  E Lemonnier; C Degrez; M Phelep; R Tyzio; F Josse; M Grandgeorge; N Hadjikhani; Y Ben-Ari
Journal:  Transl Psychiatry       Date:  2012-12-11       Impact factor: 6.222

10.  Changes in EEG complexity with electroconvulsive therapy in a patient with autism spectrum disorders: a multiscale entropy approach.

Authors:  Ryoko Okazaki; Tetsuya Takahashi; Kanji Ueno; Koichi Takahashi; Makoto Ishitobi; Mitsuru Kikuchi; Masato Higashima; Yuji Wada
Journal:  Front Hum Neurosci       Date:  2015-02-26       Impact factor: 3.169

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.